Nurix Therapeutics, Inc. NRIX
Regular-session close
After hours · Nov 16, 4:26 PM ET
- YTD
- -22.35%
- 1 year
- +15.08%
NRIX free cash flow history
Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.
-263,467,000 USD
FY 2025 · Period ended
Coverage: complete. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.
Missing observations.
Scroll the table to see all values →
| Fiscal period | Period end | Free cash flow | YoY change | YoY % |
|---|---|---|---|---|
| FY 2025 | 2025-11-30 | -263,467,000 | -81,610,000 | Not meaningful |
| FY 2024 | 2024-11-30 | -181,857,000 | -92,091,000 | Not meaningful |
| FY 2023 | 2023-11-30 | -89,766,000 | 82,285,000 | Not meaningful |
| FY 2022 | 2022-11-30 | -172,051,000 | -82,025,000 | Not meaningful |
| FY 2021 | 2021-11-30 | -90,026,000 | -85,393,000 | Not meaningful |
| FY 2020 | 2020-11-30 | -4,633,000 | -3,583,000 | Not meaningful |
| FY 2019 | 2019-11-30 | -1,050,000 | Not available | Not available |
| FY 2018 | 2018-11-30 | Not available | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2026-07-13T06:02:05.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.
